📰 Nasdaq Cgem News
Nasdaq Cgem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Cgem. Real-time updates on events, politics, business and more.
May 5, 2024
Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $40.00 price objective on the stock. Several other brokerages have also weighed in on CGEM. HC Wainwright decreased their price objective on Cullinan Oncology […]
January 31, 2024
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) insider Corrine Savill sold 40,000 shares of the firm’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $14.09, for a total transaction of $563,600.00. Following the transaction, the insider now directly owns 165,990 shares in the company, valued […]
December 30, 2023
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CEO Nadim Ahmed sold 4,272 shares of Cullinan Oncology stock in a transaction dated Tuesday, December 26th. The stock was sold at an average price of $9.24, for a total value of $39,473.28. Following the sale, the chief executive officer now directly owns 111,550 shares of the […]
December 23, 2023
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) insider Jeffrey Alan Jones sold 1,860 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $8.50, for a total value of $15,810.00. Following the sale, the insider now directly owns 56,191 shares of the company’s […]
December 23, 2023
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CFO Jeffrey Trigilio sold 1,920 shares of the company’s stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $8.50, for a total transaction of $16,320.00. Following the completion of the sale, the chief financial officer now directly owns 83,919 […]
December 15, 2023
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CFO Jeffrey Trigilio sold 1,926 shares of the stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $7.81, for a total value of $15,042.06. Following the sale, the chief financial officer now owns 86,237 shares of the […]
November 27, 2023
SVB Financial Group decreased its position in Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 33.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,516 shares of the company’s stock after selling 6,758 shares during the period. Cullinan Oncology […]
October 2, 2023
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 2,180,000 shares, a decline of 17.7% from the August 31st total of 2,650,000 shares. Based on an average trading volume of 189,900 shares, […]
September 11, 2023
EcoR1 Capital LLC cut its stake in shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 76.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 246,410 shares of the company’s stock after selling 788,628 shares during the quarter. EcoR1 […]
September 11, 2023
EcoR1 Capital LLC cut its holdings in Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 76.2% during the first quarter, Holdings Channel reports. The institutional investor owned 246,410 shares of the company’s stock after selling 788,628 shares during the quarter. EcoR1 Capital LLC’s holdings in Cullinan Oncology were worth $2,521,000 at the end of the […]